Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.78 is 15% below its 5-year average of 5.65, near the low end of its 5-year range (3.83–7.81).
As of the fiscal period ended Tuesday, June 30, 2026. 19.30% below its 12-month average of 5.92.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.78.
CURRENT RATIO
4.78
CURRENT RATIO AVG TTM
5.92
CURRENT RATIO AVG 3Y
5.73
CURRENT RATIO AVG 5Y
5.65
CURRENT RATIO AVG 10Y
5.59
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-19.30%
CURRENT VS 3Y AVG
-16.61%
CURRENT VS 5Y AVG
-15.49%
CURRENT VS 10Y AVG
-14.54%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.34
median of 568 covered companies
CURRENT VS SECTOR MEDIAN
+42.83%
vs the sector median at left
Market Cap
$572.90M
Current Ratio
5.42
TTM Avg
12.18
3Y Avg
12.18
5Y Avg
12.18
Market Cap
$563.35M
Current Ratio
7.19
TTM Avg
3.91
3Y Avg
2.77
5Y Avg
2.56
Market Cap
$565.64M
Current Ratio
3.46
TTM Avg
4.63
3Y Avg
6.00
5Y Avg
6.13
Market Cap
$602.48M
Current Ratio
6.06
TTM Avg
2.91
3Y Avg
9.31
5Y Avg
9.54
Market Cap
$557.41M
Current Ratio
9.36
TTM Avg
2.17
3Y Avg
1.76
5Y Avg
2.63
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OrthoPediatrics Corp. (KIDS) | $583.05M | 4.78 | 5.92 | 5.73 | 5.65 |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $572.90M | 5.42 | 12.18 | 12.18 | 12.18 |
| Aquestive Therapeutics, Inc. (AQST)vs › | $563.35M | 7.19 | 3.91 | 2.77 | 2.56 |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $565.64M | 3.46 | 4.63 | 6.00 | 6.13 |
| CorMedix Inc. (CRMD)vs › | $564.07M | 2.56 | 2.75 | 5.48 | 7.66 |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $602.48M | 6.06 | 2.91 | 9.31 | 9.54 |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $557.41M | 9.36 | 2.17 | 1.76 | 2.63 |
| Delcath Systems, Inc. (DCTH)vs › | $541.64M | 9.83 | 11.46 | 6.57 | 5.79 |
| AngioDynamics, Inc. (ANGO)vs › | $620.40M | 2.19 | 2.20 | 2.12 | 2.14 |
Current Ratio
4.78
Quick Ratio
2.17
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.78 |
| 2026-03-31 | 5.21 |
| 2025-12-31 | 5.55 |
| 2025-09-30 | 7.40 |
| 2025-06-30 | 6.66 |
| 2025-03-31 | 6.19 |
| 2024-12-31 | 6.98 |
| 2024-09-30 | 7.17 |
| 2024-06-30 | 4.90 |
| 2024-03-31 | 4.45 |
| 2023-12-31 | 5.44 |
| 2023-09-30 | 4.72 |
| 2023-06-30 | 5.04 |
| 2023-03-31 | 6.39 |
| 2022-12-31 | 7.34 |
| 2022-09-30 | 7.81 |
| 2022-06-30 | 4.75 |
| 2022-03-31 | 3.83 |
| 2021-12-31 | 4.50 |
| 2021-09-30 | 4.83 |
| 2021-06-30 | 4.79 |
| 2021-03-31 | 4.15 |
| 2020-12-31 | 4.52 |
| 2020-09-30 | 6.27 |
| 2020-06-30 | 7.28 |
| 2020-03-31 | 8.32 |
| 2019-12-31 | 9.37 |
| 2019-09-30 | 2.35 |
| 2019-06-30 | 2.53 |
| 2019-03-31 | 8.60 |
| 2018-12-31 | 10.54 |
| 2018-09-30 | 5.67 |
| 2018-06-30 | 5.98 |
| 2018-03-31 | 6.24 |
| 2017-12-31 | 7.35 |
| 2017-09-30 | 2.77 |
| 2017-06-30 | 1.83 |
| 2017-03-31 | 2.64 |
| 2016-12-31 | 2.87 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 2.98 |
| 2015-03-31 | 0.00 |
